MEAKSS, a synthetic heptapeptide, is emerging as a promising agent for neurodegenerative disorders. Derived from the ACTH 4-10 fragment, MEAKSS demonstrates remarkable neuroprotective effects by influencing key cellular pathways involved in neuronal maintenance. Studies suggest that MEAKSS can promote neuronal growth, {reduceneurotoxicity, and opti